Epigral Ltd · NSE:EPIGRAL
Epigral — Meghmani Finechem — Q2 FY2022 Earnings Presentation
20 slides from Epigral's earnings presentation, Oct 26, 2021
Slide 1: Exchange filing cover letter for Q2 FY22 earnings presentation
MEGHMANI FINECHEM LTD. Regd. Office: CH/1, CH/2, GIDC Industrial Estate, Dahej, Tai. Vagra, Bharuch - 392 130. Gujarat, (INDIA) Phone: +91- 635 9953661/62/63/64/65, E-mail : helpdesk@meghmanifinechem.com, URL: www.meghmanifinechem.com GIN: L241 OOGJ2007PLC051717 26.10.2021 To, National Stock Exchang
Slide 2: Meghmani Finechem Limited Q2FY22 Earnings Presentation
MEGHMANI FINECHEM LIMITED Q2FY22 Earnings Presentation 26th October, 2021
Slide 3: Disclaimer
tJ Disclaimer lrwFL Your ('>Stntial~. Ou r c,q,e rti se. This presentation and the accompanying slides (the “Presentation”), which have been prepared by Meghmani Finechem Limited (the “Company”) solely for the information purposes and do not constitute any offer, recommendation or invitation to purc
Slide 4: Company Overview
Company Overview The Next Gen Business l:----------------- ----------------------------- !i----------- ----------------------------- Founded: 1 21% 16% I , I 2007 I I I ' I I _____ ,I ------------------------------ l ---------------------------- ------•! I 4 Year Revenue CAGR (FY21) 4 Year EBITDA CA
Slide 5: Key Highlights
tJ Key Highlights lrwFL Your ('>Stntial~. Ou r c,q,e rti se. Operational Highlights: o Overall plant utilization improved by 16% YoY to 90% in Q2FY22. o H202 Plant capacity ramped up and at 85% utilization in Q2FY22 o In Q2FY22, Caustic Soda ECU realisation up 28% YoY; Caustic Potash up 5% on a YoY
Slide 6: CMD Message
tJ CMD Message lrwFL Your ('>Stntial~. Ou r c,q,e rti se. “We are delighted with the stellar performance delivered in H1FY22. Our plants have achieved higher capacity utilization and our projects are on track for completion as per the schedule provided. While the demand environment remains robust ou
Slide 7: H1FY22 Operational Overview
tJ H1FY22 Operational Overview lrwFL Your ('>Stntial~. Ou r c,q,e rti se. Production(‘000 MT) Capacity Utilisation 128 90 107% 78% 87% 88% 95% 80% 75% 24 27 24 28% 8 9 3 Casutic Soda Caustic Potash Chloromethanes Hydrogen Caustic Soda Caustic Potash Chloromethanes Hydrogen Peroxide Peroxide ■ H1FY21
Slide 8: H1FY22 Financial Highlights
H1FY22 Financial Highlights Yo ur (•~St'nlidl'.), Our c.11. r,c: rt isr. Revenue from operations & EBITDA & EBITDA Margin PAT & PAT Margin Gross Margin 54.2% 47.6% 32.3% 30.6% 12.5% 13.3% 630 193 84 349 113 44 H1FY21 H1FY22 H1FY21 H1FY22 H1FY21 H1FY22 Numbers are in ₹ Cr o Revenue from operations in
Slide 9: Q2FY22 Operational Overview
tJ Q2FY22 Operational Overview lrwFL Your ('>Stntial~. Ou r c,q,e rti se. Production(‘000 MT) Capacity Utilisation 64 107% 55 88% 90% 87% 103% 85% 74% 13 13 13 28% 5 5 3 Casutic Soda Caustic Potash Chloromethanes Hydrogen Caustic Soda Caustic Potash Chloromethanes Hydrogen Peroxide Peroxide ■ Q2FY21
Slide 10: Operational overview (ECU & Sales realization)
tJ Operational overview (ECU & Sales realization) lrwFL Your ('>Stntial~. Ou r c,q,e rti se. Q2FY22 - Change in ECU and Sales Caustic Soda ECU (Rs) Realization/MT Realization % YoY 53% 27,201 25,183 28% 23,246 21,798 21,270 5% 1% Caustic Soda - ECU Caustic Potash - Chloromethanes Hydrogen Q2FY21 Q3F
Slide 11: Q2FY22 Financial Highlights
Q2FY22 Financial Highlights Your ('>Stntial~. Ou r ('J,q,e rti se . Revenue from operations EBITDA & EBITDA Margin PAT & PAT Margin & Gross Margin ._________, 55.4% [ I 50.1% I .____I_____. 45.5% 33.9% [ I 31.9% I ~I~ .____________. 29.6% 12.2% I 12.7% I I._________. ._________,[ 13.8% 340 290 101 9
Slide 12: H1FY22 Key Ratios
tJ H1FY22 Key Ratios lrwFL Your ('>Stntial~. Ou r c,q,e rti se. ROCE (%) ROE (%) Debt*/EBITDA (x) 23.1% 27.1% 2.2 15.7% 2.1 15.1% FY21 H1FY22 FY21 H1FY22 FY21 H1FY22 All the above ratios are annualized. * Debt includes working capital o ROCE% and ROE% improved on account of higher ECU realization of
Slide 13: Debt Maturity Profile as on 30-09-2021
tJ Debt Maturity Profile as on 30-09-2021 lrwFL Your ('>Stntial~. Ou r c,q,e rti se. Long Term Debt *– ₹ 811 Cr 35% 18% 15% 16% 10% 6% 1 Year 2 Years 3 Years 4 years 5 Years > 5 years *Includes preference shares of Rs. 211 Cr reclassified as debt according to Scheme of Arrangement Above does not inc
Slide 14: Chlor-Alkali vs Derivatives (CMS & H2O2)
tJ Chlor-Alkali vs Derivatives (CMS & H202) lrwFL Your ('>Stntial~. Ou r c,q,e rti se. Diversification on Track; Business Model being De-Risked Derivatives Derivatives 25% 31% H1FY21 H1FY22 Chlor-Alkali ₹ 349 Cr Chlor-Alkali ₹ 630 69% 75% 13 | MEGHMANI FINECHEM LIMITED
Slide 15: Projects Update
Projects Update Your ('>Stntial~. Ou r ('J,q,e rti se. CAPEX PLANS Expected ■ Increase ■ Decrease ■ Tota I Product Capacity Commissioning 800 Date 695 700 600 210 Epichlorohydrin 50KTPA Q1FY23 500 400 120 CPVC Resin 30KTPA Q2FY23 300 230 200 135 100 Additional Caustic 106KTPA Q2FY23 Capacity 0 FY21
Slide 16: Focused on ESG
Focused on ESG ENVIRONMENT o Focused on using best technology to manage critical resources, to moderate the consumption of energy and natural resources and drive operations efficiently o Focus is to manufacture more from less, basis for environment responsibility o Commitment towards reduce energy i
Slide 17: Income Statement
Income Statement Your ('>Stntial~. Ou r ('J,q,e rti se. Particulars (₹ Cr) Q2FY22 Q2FY21 % Change H1FY22 H1FY21 % Change Revenue from Operations 340 211 61% 630 349 81% Gross Profit 155 117 32% 300 189 59% Gross Margin (%) 45.5% 55.4% 47.6% 54.2% EBITDA 101 71 41% 193 113 71% EBITDA Margin (%) 29.6%
Slide 18: Historic Income Statement
Historic Income Statement Your ('>Stntial~. Ou r ('J,q,e rti se. Particulars (₹ Cr) FY17 FY18 FY19 FY20 FY21 Total Revenue 393 602 720 613 831 Gross Profit 167 359 455 335 443 Gross Margin (%) 43% 60% 64% 55% 53% EBITDA 144 255 312 194 261 EBITDA Margin (%) 37% 43% 44% 32% 32% Depreciation 55 55 54
Slide 19: Historic Balance Sheet
Historic Balance Sheet Your ('>Stntial~. Ou r ('J,q,e rti se. Assets (₹ Cr) FY20 FY21 H1FY22 Liabilities (₹ Cr) FY20 FY21 H1FY22 Fixed Assets 1,131 1,228 1,416 Share Capital 42 42 42 Financial Assets 4 10 10 Reserves & Surplus 542 643 516 Other Non-current Assets 5 29 57 Long-Term Borrowings 418 340
Slide 20: About Us & Investor Contact
tJ About Us & Investor Contact lrwFL Your ('>Stntial~. Ou r c,q,e rti se. Meghmani Finechem Limited (“MFL”), incorporated in 2007, is a leading manufacturer of Chlor-Alkali products and value-added derivatives. The company has state of the art manufacturing facilities in Gujarat, Dahej – a leading P